BioSpace News Archive

New Access Accelerated Global Collective Report Charts Path Forward in Fight Against Noncommunicable Diseases

Access Accelerated announced the release of a six-year report: Key Lessons in Advancing Access to NCD Care: Collaboration, Connectivity, Community.

May 24, 2023
·
3 min read
RayCare is interoperable with Varian TrueBeam

RaySearch Laboratories AB is proud to announce that the oncology information system RayCare®* can connect to Varian TrueBeam® linear accelerators.

May 24, 2023
·
2 min read
Genetown

Institute of Oncology Ljubljana Leverages SOPHiA DDM™ Platform for Cancer Research

SOPHiA GENETICS announced that the Institute of Oncology Ljubljana, a comprehensive public institution for detection, treatment and research of cancer, based in Ljubljana, Slovenia, is live on SOPHiA DDM™.

May 24, 2023
·
4 min read
Genetown

ElevateBio Announces $401 Million Series D Financing to Further Accelerate Growth

ElevateBio, LLC announced the closing of its $401 million Series D financing led by the AyurMaya Capital Management Fund, managed by Matrix Capital Management, and joined by a leading group of new and existing investors.

May 24, 2023
·
5 min read
BioForest

Kineta Set to Join Russell Microcap® Index

Kineta, Inc. announced that the company is set to join the Russell Microcap® Index at the conclusion of the 2023 Russell indexes annual reconstitution, effective after the US market opens on June 26, 2023, according to a preliminary list of additions posted on May 19, 2023.

May 24, 2023
·
6 min read
Genetown

Nuvalent to Participate in the TD Cowen 4th Annual Oncology Innovation Summit

Nuvalent, Inc. announced that James Porter, Ph.D., Chief Executive Officer, and Alexandra Balcom, Chief Financial Officer, will participate in a fireside chat during the TD Cowen 4th Annual Oncology Innovation Summit on Wednesday, May 31, 2023, at 10:30 a.m. ET.

May 24, 2023
·
1 min read
Drug Development

AlzeCure Announces Positive Phase IIa Clinical Study Data in Neuropathic Pain with the Non-opioid ACD440

AlzeCure Pharma announced that the company has received positive data from the Phase IIa clinical study with the non-opioid drug candidate ACD440, which is developed against peripheral neuropathic pain.

May 24, 2023
·
6 min read
Deals

Pyxis Oncology to Acquire Apexigen

Pyxis Oncology, Inc. and Apexigen, Inc. announced a definitive agreement by which Pyxis Oncology will acquire Apexigen in an all-stock transaction for an implied value of $0.64 per Apexigen share.

May 24, 2023
·
15 min read
Business

Centene Corporation Announces New Chief Communications Officer

Centene Corporation, a leading healthcare enterprise committed to helping people live healthier lives, announced it has named Shannon T. Susko as its Senior Vice President and Chief Communications Officer.

May 24, 2023
·
9 min read
Business

Kamada Reports Strong First Quarter 2023 Financial Results; Reiterates Revenue and Profitability Guidance

Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a commercial stage global biopharmaceutical company, with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today announced financial results for three months ended March 31, 2023.

May 24, 2023
·
20 min read